Major Depressive Disorder (MDD) is a debilitating condition characterized by persistent feelings of sadness, hopelessness, and a lack of interest in daily activities. Understanding its underlying causes and effective treatments is crucial for patient well-being. The Journal of Clinical Psychiatry provides a comprehensive look into MDD, offering evidence-based therapeutic approaches and the latest research findings. Our expert editors ensure content is relevant and actionable, aiding psychiatrists in offering holistic care to those grappling with depression.
Depression and Major Depressive Disorder
Page 31
Recently published articles about Depression (MDD)
Letter to the Editor
BMI and Remission in Depressed Patients Receiving IV Ketamine
November 12, 2019
Few studies have evaluated optimal dosing of intravenous (IV) ketamine for treatment-resistant depression (TRD). This report analyzes data from previous studies of IV ketamine to assess the association between...
Original Research
Utility of Combinatorial Pharmacogenomics in Depression
October 31, 2019
This study sought to ascertain the extent that pharmacogenetic testing can inform treatment decisions among patients with treatment-resistant depression whose medications are subject to gene-drug interactions—read the article to...
Original Research
Metabolic Syndrome in Treatment-Resistant Depression
October 15, 2019
This study aimed to estimate the prevalence of metabolic syndrome and its components in patients with treatment-resistant depression and determine correlations with sociodemographic, clinical, and treatment-related factors—read the article...
Case Report
Lithium Treatment in a Depressed Child at Risk for Bipolar Disorder
October 10, 2019
Treatment of severely depressed children at risk for bipolar disorder is challenging. Read about an 11-year-old girl with depression, suicidal ideation, and family history of bipolar disorder whose symptoms...
